Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Covington
Teva
AstraZeneca
US Department of Justice
Deloitte
Queensland Health
McKinsey

Generated: February 18, 2019

DrugPatentWatch Database Preview

Drug Price Trends for ASPIRIN EC

« Back to Dashboard

Drug Price Trends for ASPIRIN EC

Average Pharmacy Cost for ASPIRIN EC

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
ASPIRIN EC 81 MG TABLET 70000-0428-01 0.01390 EACH 2019-02-13
ASPIRIN EC 81 MG TABLET 46122-0262-48 0.01390 EACH 2019-02-06
ASPIRIN EC 325 MG TABLET 00536-3313-01 0.01588 EACH 2019-01-23
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
US Department of Justice
Colorcon
Medtronic
Cantor Fitzgerald
Johnson and Johnson
Farmers Insurance
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.